Related Experiment Video
Updated: May 12, 2026
08:59
A Freeze-Thawing Method to Prepare Chitosan-Poly(vinyl alcohol) Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
Published on: January 14, 2020
Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process
A S Paulino1, G Rauber, C E M Campos
1Programa Pós-Graduação em Farmácia, Universidade Federal de Santa Catarina, Florianópolis, Brazil. amarilis_paulino@yahoo.com.br
Summary
Antisolvent crystallization created hollow Deflazacort (DFZ) crystals, significantly improving its dissolution rate and bioavailability compared to micronized forms. This technique enhances poorly soluble drug delivery.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Chemical Engineering
Background:
- Deflazacort (DFZ), a prednisolone derivative, is a poorly soluble corticosteroid with limited bioavailability.
- Micronization, a common strategy to enhance drug dissolution, can negatively impact solid-state properties like fluidity and wettability.
- Alternative crystallization techniques are needed to improve the dissolution and stability of poorly soluble drugs.
Purpose of the Study:
- To investigate the antisolvent crystallization of Deflazacort (DFZ) to improve its dissolution properties.
- To compare the physicochemical properties and dissolution profiles of DFZ obtained via antisolvent crystallization with raw and micronized materials.
- To explore the potential of antisolvent crystallization as a strategy for enhancing the bioavailability of poorly soluble drugs.
Main Methods:
- Antisolvent crystallization of DFZ was performed using varying solvent systems (methanol/water) and preparation conditions (stirring, evaporation rates).
- Physicochemical properties including crystalline structure, morphology, and particle size were analyzed.
- Intrinsic Dissolution Rate (IDR) and dissolution profiles were evaluated and correlated with solid-state properties.
Main Results:
- Antisolvent crystallization successfully produced hollow-shaped DFZ crystals with internal channels.
- These hollow crystals exhibited a significantly increased dissolution rate compared to raw and micronized DFZ.
- The observed improvements in dissolution are attributed to the unique morphology achieved through antisolvent crystallization.
Conclusions:
- Antisolvent crystallization is a promising technique for producing Deflazacort (DFZ) with enhanced dissolution properties.
- The formation of hollow crystals via this method offers a viable strategy to improve the bioavailability of poorly soluble drugs.
- This approach provides an alternative to micronization, mitigating its associated drawbacks.
Related Concept Videos
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
01:16Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:10Recrystallization: Solid–Solution Equilibria
Recrystallization is a purification technique used to separate impurities from solid compounds. In this technique, no chemical reactions occur. Instead, it exploits physical properties only, specifically, the solubility differences between the desired compound and impurities, either at a single temperature or at different temperatures, and under other selected conditions. The solid-solution equilibrium (solubility equilibrium) of each component in the solution represents a binary phase...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...